Zeer Novocure / intent / novocure

Novocure

1001-5000 employees·Baar, Switzerland·novocure.com

Observed, not inferred · updated weekly

Buying intent

26 tracked signals | Top 15 topics are below | Engineering and Marketing are carrying most of it.

16signals · 30 days
25topics tracked
57.14%attributed to a team

Attention by team

LinkedIn activity, by team

Where Novocure's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Artificial Intelligence
Software Quality
Medical Devices
Healthcare Service Providers
Precision Medicine
Order To Cash
Engineering
Engineering to Artificial Intelligence: no signal
Medium50% of team Engineering to Software Quality: Medium, 50% of this team's signals
Medium50% of team Engineering to Medical Devices: Medium, 50% of this team's signals
Engineering to Healthcare Service Providers: no signal
Engineering to Precision Medicine: no signal
Engineering to Order To Cash: no signal
Marketing
Marketing to Artificial Intelligence: no signal
Marketing to Software Quality: no signal
Marketing to Medical Devices: no signal
Marketing to Healthcare Service Providers: no signal
Medium100% of team Marketing to Precision Medicine: Medium, 100% of this team's signals
Marketing to Order To Cash: no signal
Operations
Operations to Artificial Intelligence: no signal
Operations to Software Quality: no signal
Operations to Medical Devices: no signal
Operations to Healthcare Service Providers: no signal
Operations to Precision Medicine: no signal
Medium100% of team Operations to Order To Cash: Medium, 100% of this team's signals
Others
High67% of team Others to Artificial Intelligence: High, 67% of this team's signals
Others to Software Quality: no signal
Others to Medical Devices: no signal
Medium33% of team Others to Healthcare Service Providers: Medium, 33% of this team's signals
Others to Precision Medicine: no signal
Others to Order To Cash: no signal
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Artificial Intelligence
LinkedIn
High volume
96%
last
5d ago
Software Quality
LinkedIn
Medium volume
96%
last
3d ago
Medical Devices
LinkedIn
Medium volume
96%
last
3d ago
Healthcare Service Providers
LinkedIn
Medium volume
94%
last
16d ago
Precision Medicine
LinkedIn
Medium volume
96%
last
14d ago
Order To Cash
LinkedIn
Medium volume
98%
last
26d ago
Medication Dispensing
LinkedIn
Medium volume
98%
last
14d ago
Strategic Planning
LinkedIn
Medium volume
96%
last
13d ago
AI Agent Software
LinkedIn
Medium volume
92%
last
5d ago
Agentic AI System
LinkedIn
Medium volume
98%
last
5d ago
Talent Management
LinkedIn
Medium volume
98%
last
3d ago
Shared Services
LinkedIn
Medium volume
96%
last
26d ago
Data Storage
LinkedIn
Medium volume
98%
last
12d ago
Career Development
LinkedIn
Medium volume
94%
last
3d ago
Event Networking and Matchmaking
LinkedIn
Medium volume
98%
last
16d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at Novocure

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others4 active
Senior ICresearching Artificial Intelligence
in
Directorresearching Healthcare Operations
in
Senior ICresearching Organizational Development
in
researching Hiring
in
Engineering2 active
researching Quality Engineering
in
researching Drug Delivery Systems
in
Operations2 active
Directorresearching Event Networking and Matchmaking
in
researching Professional Development
in
Marketing1 active
researching Precision Medicine
in

Primary products / business lines

LinkedIn company profile

Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, non-small cell lung cancer, malignant pleural mesothelioma and pleu

Top accounts researching Novocure

names withheld on the public page

These are companies whose own people brought up Novocure unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

129,094 companies · 649,540 people are researching Artificial Intelligence

Novocure's own team shows 2 signals on this topic. No one outside Novocure has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.

  • Software Quality1,363 cos · 3,977 people
  • Medical Devices2,158 cos · 7,234 people
Sign up to see which companies →

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching Novocure.

Company size breakdown
Buyer seniority mix

Sign up to learn more

Create an account to explore buyer insights as they become available.

Sign up to learn more →

Buying committee functions

Employee job titles (LinkedIn)

Product — 1 person; Data / Analytics — 1 person; Engineering — 1 person; Marketing — 1 person

What's been said

public posts by Novocure's team

No public post naming Novocure has surfaced in the past year, so this is what Novocure's own team is posting about publicly — their topics, in their words.

LinkedInArtificial Intelligence

A coffee with the right person can surface more insights than a full slide deck! This week I spoke with Edoardo GATTI , a procurement manager who just started a new two-year assignment in France, after completing a two-year mission in Italy—still with the same global manufacturer of industrial machines. We ended up on a topic many of us are living right now: In VUCA times, what will really help organizations navigate flooding, drought, energy shocks, geopolitical disruptions—when everything feels “simultaneously urgent”? We agreed on a balanced view. Humans can still tackle crises directly. When factories are at risk, transport routes are disrupted, energy prices spike, or water availability changes overnight, what matters is judgment, coordination, and decisive trade-offs—often with imperfect data and real consequences for people. AI will accelerate the preparation and execution of interactions. Faster scenario modeling, quicker supplier insights, better forecasting signals, more efficient sourcing workflows. In many cases, AI will make the process dramatically better—especially the speed and quantity of information. And that led us to Supplier Days, also discussed few days ago with Sammy Rashed and some colleagues at the EU Procurement Think Tank. We see a future where “Supplier Days” are no longer a once-a-year event, but a continuous, embedded practice—supported by AI: * always-on supplier performance and risk signals * continuous value engineering and cost opportunities * structured innovation pipelines * smarter collaboration rhythms across categories and functions That’s a powerful lever for sourcing professionals: a constant engine for cost improvement and resilience. But we also aligned on one essential point: AI can speed up the cycle. Humans must make the final call. Because the “best” decision isn’t always the cheapest or the fastest. It’s the one that balances continuity, competitiveness, and fairness—across suppliers, workers, communities, and the planet. In short: AI can help us execute better. Humans still define what “better” means.” Especially when it’s about people’s lives. #sourcing #ai #leadership

May 2026
LinkedIn

The first breakdown in most systems is rarely effort. It’s clarity. Not dramatic failure. Not incompetence. Just a slow accumulation of uncertainty that spreads through teams, vendors, departments, boards, and organizations like hairline fractures through glass. People start interpreting instead of executing. One person thinks the priority is speed. Another thinks it’s cost. Another assumes someone else owns the issue. Nobody is fully wrong. But the system still fails. I’ve seen this happen in manufacturing plants, supply chains, nonprofit boards, and municipal government. Though the environments may change. The pattern doesn’t. A production delay traces back to unclear ownership. A vendor misses expectations that were never fully defined. A town ordinance creates conflict because interpretation replaced precision. A nonprofit loses momentum because everyone supports the mission differently. Clarity is not micromanagement. It is the removal of unnecessary ambiguity. Good leaders do not leave critical expectations open to interpretation. Instead, they define ownership, standards, timelines, escalation paths and what success actually looks like. Because confusion compounds downstream. In operations, it becomes delays and rework. In leadership, it becomes frustration and distrust. In government, it becomes inconsistency and conflict. The cost of unclear expectations is almost never paid upfront. It gets paid later, with interest. Clarity is not about controlling people. It is about giving systems the stability required to function under pressure.

May 2026
LinkedIn

Well, I have moved into the next phase of life. I have officially retired.

May 2026
LinkedIn

If anyone is looking for an entry-level sales representative, look no further. He might also get some solid coaching and mentoring at home. ☺️😉

May 2026
LinkedIn

there are many factors that are working against the game development industry. This is just one more straw on the pile.

Apr 2026
Straight from Novocure: 5 earnings calls and filings read in full. Leadership's own words on the public record — not analyst commentary.

Strategic priorities

Earnings call; SEC filings

Financial Performance

Budget pressure / cost-cutting signal

Earnings call; SEC filings

Cost of Revenue: 4,11,06,000 USD

What changed recently

Earnings call; SEC filings

Financial Performance

About this data. Novocure (novocure.com). Department attribution is 57.14%; remaining activity is grouped under Others. Updated 2026-09-25T18:00:10.181Z.

Not yet computedPer-team narrative summaries